Accéder au contenu
Merck

Effects of coumestrol administration to maternal mice during pregnancy and lactation on renal Ca metabolism in neonatal mice.

Animal science journal = Nihon chikusan Gakkaiho (2012-06-15)
Michihisa Ueda, Yoshihiro Horiguchi, Miki Sugimoto, Shuntaro Ikeda, Shinichi Kume
RÉSUMÉ

The present study was conducted to clarify the effects of coumestrol administration to maternal mice during pregnancy and lactation on serum Ca and Ca metabolism in their neonatal mice. From 6.5 to 16.5 days post coitus and from 3 to 10 days after parturition, maternal mice were administered at 200 µg/kg body weight/day of coumestrol. Coumestrol administration did not affect weight gains, serum Ca and the expression of vitamin D receptor (VDR) protein in the kidney of neonatal mice, but weight gains of maternal mice were decreased by coumestrol administration. Coumestrol administration increased the messenger RNA (mRNA) expressions of epithelial Ca channels 1 (ECaC1) and VDR in the kidney of neonatal mice, and also increased the mRNA expressions of ECaC2 in the kidney and small intestine of male neonatal mice. The mRNA expressions of ECaC1, ECaC2, calbindin-D(9k) (CaBP-9k) and estrogen receptor (ER)α in the kidney and VDR in the small intestine of male neonatal mice were higher than those of female mice. Thus, coumestrol administration to maternal mice during pregnancy and lactation may affect renal Ca metabolism in neonatal mice, especially male neonatal mice via maternal milk.

MATÉRIAUX
Référence du produit
Marque
Description du produit

Sigma-Aldrich
Coumestrol, ≥95.0% (HPLC)
Sigma-Aldrich
Coumestrol, BioReagent, suitable for fluorescence, ≥97.5% (HPLC)